These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6980547)
1. Adriamycin cardiotoxicity. Prognostic value of the systolic time intervals. Chaudron JM; Beauduin M; Delwiche JP; Delannoy A; Luwaert R; Majois F; Lebacq EG; Pluygers E Acta Cardiol; 1982; 37(2):105-15. PubMed ID: 6980547 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals. Villani F; Beretta G; Guindani A Cancer Chemother Pharmacol; 1979; 3(4):249-51. PubMed ID: 535135 [TBL] [Abstract][Full Text] [Related]
3. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output]. Pelosi G; Bracchi G; Orazio S; Cereda A Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220 [TBL] [Abstract][Full Text] [Related]
4. [Prospective monitoring of adriamycin cardiotoxicity with systolic time intervals]. Nakamura K; Miyake T; Kawamura T; Maekawa I Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1633-7. PubMed ID: 3193011 [No Abstract] [Full Text] [Related]
5. [Monitoring of Myocardial function during therapy with cardiotoxic cytostatics. Studies with the example of anthracycline-containing chemotherapy]. Richter-v Arnauld HP; Kleeberg UR; Hassel C; Spehn J; Erdmann H Onkologie; 1982 Aug; 5(4):168-73. PubMed ID: 6755329 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
7. Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia. Al-Ismail S; Whittaker JA Br Med J; 1979 May; 1(6175):1392-5. PubMed ID: 286623 [TBL] [Abstract][Full Text] [Related]
8. [Systolic time intervals and echocardiography in monitoring adriamycin-treated tumor patients]. Schott G Z Gesamte Inn Med; 1991 Jun; 46(8):280-2. PubMed ID: 1897287 [TBL] [Abstract][Full Text] [Related]
9. [Determination of systolic time intervals in healthy and in adriamycin-treated children]. Kasih EN; Hoffmann W Klin Padiatr; 1984; 196(6):360-6. PubMed ID: 6513423 [TBL] [Abstract][Full Text] [Related]
10. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin. Buch J; Rasmussen S Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of doxorubicin cardiotoxicity in patients treated intermittently with beta-methyldigoxin. Villani F; Comazzi R; Di Fronzo G; Bertuzzi A; Guindani A Tumori; 1982 Aug; 68(4):349-53. PubMed ID: 7147362 [TBL] [Abstract][Full Text] [Related]
12. The left ventricular systolic function after digoxin administration in patients with chronic renal failure. Trznadel K; Luciak M; Wyszogrodzka M Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145 [TBL] [Abstract][Full Text] [Related]
13. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol]. Rossi A; Ziacchi V; Lomanto B Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529 [TBL] [Abstract][Full Text] [Related]
14. Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy. Sanyal SK; Tierney RC; Rao PS; Pitner SE; George SL; Givins DR Pediatrics; 1982 Dec; 70(6):958-64. PubMed ID: 7145553 [TBL] [Abstract][Full Text] [Related]
15. [Echocardiographic detection of adriamycin cardiotoxicity. Study of the relationship between the shortening fraction-constraint and the systolic shortening fraction-diameter of the left ventricle]. Boujon B; Lechat P; Mantz J; Fraysse JB; Leblond V; Drobinski G; Lascault G; Grosgogeat Y Arch Mal Coeur Vaiss; 1989 Feb; 82(2):167-75. PubMed ID: 2500077 [TBL] [Abstract][Full Text] [Related]
16. [Monitoring of cardiac function during doxorubicin therapy in metastasized breast cancer. Measuring systolic time interval]. Lenzhofer R; Dudczak R; Dittrich C; Gumhold G; Moser K; Spitzy KH Dtsch Med Wochenschr; 1983 May; 108(20):771-5. PubMed ID: 6840008 [TBL] [Abstract][Full Text] [Related]
17. Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity. Rousson D; Galleyrand J; Silie M; Boissel JP Eur J Clin Pharmacol; 1987; 31(5):559-62. PubMed ID: 3830241 [TBL] [Abstract][Full Text] [Related]
18. On the reliability of systolic time intervals. Levi GF; Ratti S; Cardone G; Basagni M Cardiology; 1982; 69(3):157-65. PubMed ID: 7127348 [TBL] [Abstract][Full Text] [Related]
19. [Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)]. Vitolo E; Larovere MT; Gambini E; Rusconi F; Vitali GM G Ital Cardiol; 1980; 10(10):1360-5. PubMed ID: 7239083 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic changes associated with angina pectoris induced by maximal treadmill exercise: effect of sublingual isosorbide dinitrate on systolic time intervals. Thompson EJ; Glass P; Ansari A; Arora J Angiology; 1976 May; 27(5):269-79. PubMed ID: 1053551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]